Physician profile
Clifford Scott Howe
NPI 1003989856
$352.04
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $121 · 2021: $69.45 · 2022: $57.16.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $93.38 | 2019-2021 | |
| Optinose US, INC. | $66.79 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $54.11 | 2021-2022 | |
| Glaxosmithkline, LLC. | $43.37 | 2021-2022 | |
| Livanova USA, INC. | $30.38 | 2019 | |
| Smith+Nephew, INC. | $16.98 | 2019 | |
| Genzyme Corporation | $12.85 | 2021 | |
| Tactile Systems Technology INC | $12.00 | 2019 | |
| Resmed Corp | $11.89 | 2020 | |
| Aerin Medical INC. | $10.29 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clifford Howe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.